Novo Nordisk A/S (CPH:NOVO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
286.50
+8.05 (2.89%)
Nov 16, 2026, 2:19 PM CET

Novo Nordisk Revenue

Novo Nordisk had revenue of 79.20B DKK in the quarter ending September 30, 2026, with 5.63% growth. This brings the company's total for the last twelve months to 333.65B, up 5.72% year-over-year. In the year 2025, Novo Nordisk had annual revenue of 309.06B with 6.43% growth. That makes Novo Nordisk the 262nd largest company in the world by revenue and 2nd in Denmark.

Revenue (ttm)
333.65B
Revenue Growth
+5.72%
P/S Ratio
3.68
Revenue / Employee
4.83M
Employees
66,700
Market Cap
1.26T

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Ozempic Injectable 127.09B 41.1%
  • Wegovy Injectable 79.11B 25.6%
  • Ozempic Pill / Rybelsus 22.09B 7.1%
  • Long-Acting Insulin 18.76B 6.1%
  • Fast-Acting Insulin 18.58B 6.0%
  • Rare Blood Disorders 11.96B 3.9%
  • Premix Insulin 10.32B 3.3%
  • Other 21.17B 6.8%

By Geography

Chart
  • US 173.17B 56.0%
  • EUCAN 66.09B 21.4%
  • Emerging Markets 30.44B 9.8%
  • APAC 20.71B 6.7%
  • China 18.66B 6.0%
Fiscal year ended Dec 31, 2025 See the full Novo Nordisk breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025309.06B18.66B6.43%
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019122.02B10.19B9.11%
Dec 31, 2018111.83B135.00M0.12%
Dec 31, 2017111.70B-84.00M-0.08%
Dec 31, 2016111.78B3.85B3.57%
Dec 31, 2015107.93B19.12B21.53%
Dec 31, 201488.81B5.23B6.26%
Dec 31, 201383.57B5.55B7.11%
Dec 31, 201278.03B11.68B17.60%
Dec 31, 201166.35B5.57B9.16%
Dec 31, 201060.78B9.70B18.99%
Dec 31, 200951.08B5.53B12.13%
Dec 31, 200845.55B3.72B8.90%
Dec 31, 200741.83B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Coloplast28.94B
Genmab28.27B
H. Lundbeck26.28B
Demant24.63B
GN Store Nord16.52B
ALK-Abelló6.83B
Embla Medical6.56B
Ambu A/S6.47B
Revenue Rankings